Actively Recruiting
Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty
Led by Zagazig University · Updated on 2025-07-15
72
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Approximately 1.66 million hip fractures happen in a year worldwide. About 95% of these fractures happen in individuals older than 60 years. Surgical treatment involving THA is considered the best option for patients with hip fractures and those with degenerative changes in the hip joint, especially in the elderly, however, it is associated with moderate to severe postoperative pain. Pain is one of the main factors limiting ambulation, increasing the risk of thromboembolism by immobility, and causing metabolic changes that affect other systems. Therefore, individualized pain management with the use of appropriate analgesia techniques is of paramount importance. Moreover, early intervention of rehabilitation aiming at a better postoperative recovery may reduce the length of hospital stay and return to daily. Effective pain management is one of the crucial components of enhanced recovery after surgery (ERAS). Numerous regional anesthetic techniques have been used to provide analgesia following THA, including intrathecal morphine, epidural analgesia, fascia iliaca block, lumber plexus block, sacral plexus block, and local infiltration analgesia, however, each of these techniques has specific limitations that prevent them from being the analgesic technique of choice for THA. Up to investigators' knowledge, there is no study done to compare the supra-iliac approach to the anterior QL block versus the Anterior iliopsoas muscle space block as pre-emptive analgesia in patients undergoing THA under general anesthesia
CONDITIONS
Official Title
Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient acceptance
- Age 50 to 80 years old
- Body mass index (BMI) of 30 kg/m2 or less
- American Society of Anesthesiologists (ASA) classification I to III
- Scheduled for elective total hip arthroplasty under general anesthesia
You will not qualify if you...
- Allergy to local anesthetic agents used in the study
- Skin lesions at the needle insertion site
- Bleeding disorders, sepsis, liver disease, or psychiatric disorders
- Pre-existing neurological deficits in the lower extremities
- History of chronic pain or current use of analgesics
- History of cognitive dysfunction or mental illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of medicine, zagazig university
Zagazig, Alsharqia, Egypt, 4115
Actively Recruiting
Research Team
S
Shereen E Abd Ellatif, MD
CONTACT
N
Naglaa F Abdelhaleem, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here